{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:56:10Z","timestamp":1791046570424,"version":"4.1.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"the genetic disease program of the sample information and resource pool, by the Science and Technology Bureau of Foshan, China","award":["No. FS0AA-KJ218-1301-0008"],"award-info":[{"award-number":["No. FS0AA-KJ218-1301-0008"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Spinal muscular atrophy (SMA) was the second most fatal autosomal recessive hereditary disease in clinic. There had been no detailed study to characterize the prevalence of SMA carrier among people in China. So, we conducted a systematic review and meta-analysis to obtain a reliable estimation of the prevalence of SMA carrier to characterize its epidemiology for the first time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We systematically searched for articles in kinds of important electronic databases, including PubMed, Embase, Wanfang Database and China National Knowledge Infrastructure (CNKI) to identify all relevant literatures about carrier rates of SMA in China. The prevalence was performed by forest plot choosing random effect models. The publication bias was evaluated by means of funnel plots and Egger test. The sensitivity analysis was carried out by the method of omitting any literature at a time. Combined with the results of subgroup analysis, the source of heterogeneity was also discussed absolutely.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 10 studies published between 2005 and 2016 were included in our analysis at last. The sample size ranged from 264 to 107,611 in included studies. The random effect models of meta-analysis showed that the overall carrier rate of SMA was 2.0% (95% confidence interval [CI], 1.7%\u20132.3%) in a heterogeneous set of studies (I<jats:sup>2<\/jats:sup>\u200a=\u200a64%). There was a gradual rise trend observed in the SMA carrier rate during the study period. The funnel plots and Egger test (Coef\u200a=\u200a0.02, t\u200a=\u200a\u22120.45, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.667\u200a&gt;\u200a.05) showed no obvious potential risk of publication bias.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The overall carrying rate of SMA was high as 2.0% and may be on a slow upward trend. So it was recommended that the countries should take active and effective measures to roll out routine prenatal screening and health genetic counseling for SMA as early as possible. What is more, further studies also need to be conducted to explore the etiology and epidemic factors of SMA to better control the risk of this common birth defect.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000018975","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T02:31:13Z","timestamp":1580351473000},"page":"e18975","source":"Crossref","is-referenced-by-count":24,"title":["The prevalence of spinal muscular atrophy carrier in China"],"prefix":"10.1097","volume":"99","author":[{"given":"Chao","family":"Li","sequence":"first","affiliation":[{"name":"Foshan Fetal Medicine Research Institute, Foshan Women and Children Hospital Affiliated to Southern Medical University, Foshan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Science & Education Division, Huangpu, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Foshan Fetal Medicine Research Institute, Foshan Women and Children Hospital Affiliated to Southern Medical University, Foshan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Foshan Fetal Medicine Research Institute, Foshan Women and Children Hospital Affiliated to Southern Medical University, Foshan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhantong","family":"Hong","sequence":"additional","affiliation":[{"name":"Foshan Fetal Medicine Research Institute, Foshan Women and Children Hospital Affiliated to Southern Medical University, Foshan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Guo","sequence":"additional","affiliation":[{"name":"Foshan Fetal Medicine Research Institute, Foshan Women and Children Hospital Affiliated to Southern Medical University, Foshan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglai","family":"Xia","sequence":"additional","affiliation":[{"name":"Foshan Fetal Medicine Research Institute, Foshan Women and Children Hospital Affiliated to Southern Medical University, Foshan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/mus.23904","article-title":"SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy","volume":"49","author":"Kissel","year":"2014","journal-title":"Muscle Nerve"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2012.01.044","article-title":"Spinal muscular atrophy: the role of SMN in axonal mRNA regulation","volume":"1462","author":"Fallini","year":"2012","journal-title":"Brain Res"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.neuron.2005.12.001","article-title":"Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease","volume":"48","author":"Monani","year":"2005","journal-title":"Neuron"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"103","DOI":"10.18388\/abp.2009_2521","article-title":"Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease","volume":"56","author":"Jedrzejowska","year":"2009","journal-title":"Acta Biochim Pol"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","article-title":"An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)","volume":"15","author":"Wirth","year":"2000","journal-title":"Hum Mutat"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Int Med"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-4755-4-3","article-title":"Assessment of funnel plot asymmetry and publication bias in reproductive health meta-analyses: an analytic survey","volume":"4","author":"Souza","year":"2007","journal-title":"Reprod Health"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychol Methods"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature","volume":"53","author":"Sterne","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s00198-016-3504-z","article-title":"Evidence does not support the alkaline diet","volume":"27","author":"Fenton","year":"2016","journal-title":"Osteop Int"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3949\/ccjm.75.6.431","article-title":"Meta-analysis: Its strengths and limitations","volume":"75","author":"Walker","year":"2008","journal-title":"Cleve Clin J Med"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/sj.ejhg.5201821","article-title":"Population screening and cascade testing for carriers of SMA","volume":"15","author":"Smith","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/sj.ejhg.5201288","article-title":"New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations","volume":"12","author":"Ogino","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1136\/jmg.40.4.e39","article-title":"Prevalence of SMN1 deletion and duplication in carrier and normal populations: implication for genetic counselling","volume":"40","author":"Cusin","year":"2003","journal-title":"J Med Genet"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/gim.2016.215","article-title":"The next generation of population-based spinal muscular atrophy carrier screening: comprehensive pan-ethnic SMN1 copy-number and sequence variant analysis by massively parallel sequencing","volume":"19","author":"Feng","year":"2017","journal-title":"Genet Med"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/GIM.0b013e318188d069","article-title":"Carrier screening for spinal muscular atrophy","volume":"10","author":"Prior","year":"2008","journal-title":"Genet Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:51:56Z","timestamp":1694821916000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018975"}},"subtitle":["Evidences from epidemiological surveys"],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000018975","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}